Milliplex map technology
Milliplex MAP technology is a multiplex assay platform developed by Merck Group. The core function of this technology is to enable the simultaneous detection and quantification of multiple analytes from a single small sample. The Milliplex MAP system utilizes color-coded magnetic beads coated with specific capture antibodies to perform multiplexed immunoassays.
Lab products found in correlation
4 protocols using milliplex map technology
Cytokine Profiling in Diabetes
Histochemical Analysis of Ocular Tissues
Investigating Inflammatory Biomarkers in Patients
Quantifying Chemokine and C3 Expression
Gene expression studies were performed using RNA isolated from tissue and cells using the Trizol (ThermoFisher) method and converted to cDNA with iScript (BioRad). Real-time PCR was performed using PrimePCR technology with commercially validated primer sequences (Biorad) and a Biorad CFX-Connect thermocycler as directed. Relative expression was calculated using the 2–ΔΔCt method with GAPDH (glyceraldehyde 3-phosphate dehydrogenase) as a reference gene. Final PCR products were resolved on a 2% agarose gel and imaged with an Azure Biosystems C-series gel documentation system (Dublin, CA) to confirm C3 expression in cell subsets.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!